{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:22:52Z","timestamp":1749406972105},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>There are limited data on whether HIV-infected children in resource-limited countries who are receiving antiretroviral therapy (ART) are able to produce sustained, protective levels of measles antibody after multiple measles vaccinations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We administered an additional measles vaccine to HIV-infected children 15 months to 12 years of age receiving ART in Nairobi, Kenya. Measles antibody concentrations were determined by enzyme-linked immunosorbent assay at enrollment, 1 month, 12 months and 24 months post revaccination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>At enrollment, 125 (54%) of 232 study participants had protective concentrations of measles antibody. Measles seropositivity increased to 98% of all children at 1 month post revaccination but decreased to 71% at 12 months and 60% at 24 months post revaccination. Measles seroconversion and sustained measles seropositivity among those who were measles seronegative at enrollment was 25% at 24 months post revaccination. In this group, 39% of children with &lt;50 copies\/mL plasma HIV RNA measles seroconverted compared to 4% of children with plasma HIV RNA \u22651000 copies\/mL (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.018).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Measles revaccination can result in a sustained antibody response in a subset of HIV-infected children receiving ART, especially among those with HIV suppression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001572","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T15:37:16Z","timestamp":1487173036000},"page":"1148-1155","source":"Crossref","is-referenced-by-count":9,"title":["Sustained Responses to Measles Revaccination at 24 Months in HIV-infected Children on Antiretroviral Therapy in Kenya"],"prefix":"10.1097","volume":"36","author":[{"given":"Laura P.","family":"Newman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Njoroge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Magaret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna H.","family":"Chohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronicah W.","family":"Gitomea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Gorstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Overbaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalton","family":"Wamalwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Maleche-Obimbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Nduati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carey","family":"Farquhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20231020","first-page":"285","article-title":"Progress toward measles preelimination\u2014African region, 2011\u20132012.","volume":"63","author":"Masresha","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-20231020","doi-asserted-by":"crossref","first-page":"e1001241","DOI":"10.1371\/journal.ppat.1001241","article-title":"Measles outbreak in Africa\u2013is there a link to the HIV-1 epidemic?","volume":"7","author":"Nilsson","year":"2011","journal-title":"PLoS Pathog"},{"key":"R3-20231020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/INF.0b013e3181903ed3","article-title":"Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination.","volume":"28","author":"Farquhar","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20231020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/519169","article-title":"Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.","volume":"196","author":"Moss","year":"2007","journal-title":"J Infect Dis"},{"key":"R5-20231020","first-page":"658","article-title":"Immune responses to measles immunization and the impacts on HIV-infected children.","volume":"31","author":"Thaithumyanon","year":"2000","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R6-20231020","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-3156.2004.01313.x","article-title":"EPI vaccines-induced antibody prevalence in 8-9 year-olds in the Gambia.","volume":"9","author":"Viviani","year":"2004","journal-title":"Trop Med Int Health"},{"key":"R7-20231020","first-page":"CD004407","article-title":"Vaccines for measles, mumps and rubella in children.","volume":"2","author":"Demicheli","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 1","key":"R8-20231020","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/infdis\/jir096","article-title":"Global eradication of measles: an epidemiologic and economic evaluation.","volume":"204","author":"Levin","year":"2011","journal-title":"J Infect Dis"},{"key":"R9-20231020","doi-asserted-by":"crossref","first-page":"20182","DOI":"10.7448\/IAS.18.1.20182","article-title":"Uptake and yield of HIV testing and counselling among children and adolescents in sub-Saharan Africa: a systematic review.","volume":"18","author":"Govindasamy","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"R11-20231020","first-page":"349","article-title":"Measles vaccines: World Health Organization position paper.","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"R12-20231020","first-page":"517","article-title":"Weekly epidemiological record.","volume":"90","year":"2015","journal-title":"Relev\u00e9 \u00c9pid\u00e9miologique Hebdomadaire"},{"key":"R13-20231020","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/INF.0000000000000332","article-title":"Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy.","volume":"33","author":"Newman","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20231020","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/JCM.38.7.2688-2695.2000","article-title":"Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.","volume":"38","author":"Emery","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R15-20231020","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1016\/S0264-410X(03)00309-8","article-title":"Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination\u2013an impact of immunosenescence.","volume":"21","author":"Trzonkowski","year":"2003","journal-title":"Vaccine"},{"key":"R16-20231020","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/JCM.42.3.1142-1148.2004","article-title":"Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.","volume":"42","author":"Boeckh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R17-20231020","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1093\/jn\/134.11.3127","article-title":"Combined measurement of ferritin, soluble transferrin receptor, retinol binding protein, and C-reactive protein by an inexpensive, sensitive, and simple sandwich enzyme-linked immunosorbent assay technique.","volume":"134","author":"Erhardt","year":"2004","journal-title":"J Nutr"},{"key":"R18-20231020","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(03)15099-4","article-title":"Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: meta-analysis.","volume":"362","author":"Thurnham","year":"2003","journal-title":"Lancet"},{"key":"R20-20231020","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers.","volume":"162","author":"Chen","year":"1990","journal-title":"J Infect Dis"},{"key":"R23-20231020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/fvl.10.75","article-title":"Immunologic basis for revaccination of HIV-infected children receiving HAART.","volume":"6","author":"Rainwater-Lovett","year":"2011","journal-title":"Future Virol"},{"key":"R24-20231020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/jis386","article-title":"Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.","volume":"206","author":"Abzug","year":"2012","journal-title":"J Infect Dis"},{"key":"R25-20231020","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/652150","article-title":"Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy.","volume":"50","author":"Aurpibul","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R26-20231020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1086\/520651","article-title":"Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.","volume":"45","author":"Aurpibul","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R27-20231020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1468-1293.2006.00409.x","article-title":"Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy.","volume":"7","author":"Aurpibul","year":"2006","journal-title":"HIV Med"},{"key":"R28-20231020","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1086\/605648","article-title":"HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.","volume":"200","author":"Nair","year":"2009","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"R29-20231020","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1093\/infdis\/jir135","article-title":"Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi.","volume":"204","author":"Fowlkes","year":"2011","journal-title":"J Infect Dis"},{"key":"R30-20231020","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/592756","article-title":"Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.","volume":"198","author":"Helfand","year":"2008","journal-title":"J Infect Dis"},{"key":"R31-20231020","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1086\/319591","article-title":"Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children.","volume":"32","author":"Berkelhamer","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R33-20231020","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nrmicro1550","article-title":"Global measles elimination.","volume":"4","author":"Moss","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"R36-20231020","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/jcm.33.4.811-815.1995","article-title":"Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.","volume":"33","author":"Ratnam","year":"1995","journal-title":"J Clin Microbiol"},{"key":"R37-20231020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/cei.12619","article-title":"T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on antiretroviral therapy in Nairobi, Kenya.","volume":"181","author":"Buechler","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"R38-20231020","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3945\/jn.111.145805","article-title":"Plasma retinol-binding protein predicts plasma retinol concentration in both infected and uninfected Cameroonian women and children.","volume":"141","author":"Engle-Stone","year":"2011","journal-title":"J Nutr"},{"key":"R39-20231020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ajcn\/79.2.218","article-title":"Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response.","volume":"79","author":"Baeten","year":"2004","journal-title":"Am J Clin Nutr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:15:38Z","timestamp":1697775338000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201712000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001572","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}